Do you want to read an article? Please log in or register.
High-sensitivity troponin I and all-cause mortality in patients with stable COPD: An analysis of the COSYCONET study
COPD
RECOMMENDED
Related content
RECOMMENDED
COPD
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials
J Antimicrob Chemother.
Wang Y, Zijp TR, Bahar MA, Kocks JWH, Wilffert B, Hak E
doi: 10.1093/jac/dky326.
RECOMMENDED
AsthmaCOPD
Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Reyes FM, Hache-Marliere M, Karamanis D, Berto CG, Estrada R, Langston M, Ntaios G, Gulani P, Shah CD, Palaiodimos L
doi: 10.3390/jcm10102087
RECOMMENDED
Pneumonia
Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1183/13993003.00524-2020.
COPD
Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
Int J Chron Obstruct Pulmon Dis.
Beier J, Mroz R, Kirsten AM, Chuecos F, Gil EG
doi: 10.2147/COPD.S121723.
COMMENTED
COPD
Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Respir Med.
Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M, Clarenbach CF
doi: 10.1016/j.rmed.2018.06.013.
Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis
COPD.
Zou Y, Xiao J, Yang DH, Li J, Chen Q
doi: 10.3109/
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
COPD
High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Greulich T, Tüffers J, Mager S, Eder A, Maxheim M, Alter P, Schmeck B, Vogelmeier CF
doi: 10.1186/s12931-020-01365-5.
RECOMMENDED
COPD
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for COPD: A Randomized, Double-Blind, Multi-Center Parallel-Group Study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C, Rossman K, St Rose E, Trivedi R, Ballal S, Darken P, Aurivillius M, Reisner C, Dorinsky P, ETHOS investigators.
doi: 10.1164/rccm.202006-2618OC